Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

79.31
Delayed Data
As of 4:02pm ET
 -0.24 / -0.30%
Today’s Change
69.90
Today|||52-Week Range
98.97
-7.82%
Year-to-Date
Pharmaceuticals are the New Bonds
5:30pm / GuruFocus News - Paid Partner Content
Merck Offers Value and Steady Dividend Growth
Aug 24 / GuruFocus News - Paid Partner Content
Can Novartis Tide Over the Alcon Crisis?
5:21pm / GuruFocus News - Paid Partner Content
Novartis Licenses Anti-PCSK9 Antibody to Cyon Therapeutics
Aug 24 / Zacks.com - Paid Partner Content
Novartis (NVS) Reports Positive Phase III Results on MS Drug
11:04am / Zacks.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
Vanda Stock Up on Favorable U.S. Court Ruling for Fanapt
9:39am / Zacks.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
Aug 24 / MotleyFool.com - Paid Partner Content
Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline
Aug 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close79.55
Today’s open79.37
Day’s range79.02 - 80.38
Volume1,485,489
Average volume (3 months)1,719,450
Market cap$184.9B
Dividend yield3.43%
Data as of 4:02pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+77.51%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.15%
Revenue growth (last year)-4.75%
P/E ratio28.6
Price/Sales4.25
Price/Book2.45

Competitors

 Today’s
change
Today’s
% change
MRKMerck+0.53+0.85%
AGNPRAAllergan plc+2.01+0.24%
PFEPfizer+0.05+0.14%
GSKGlaxoSmithKline-0.19-0.43%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$1.20
Annual revenue (last year)$49.4B
Annual profit (last year)$17.8B
Net profit margin14.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts

Partner Offers

Search for Jobs